27.47 USD
↘ 1.64 (5.63%)AT CLOSE (11:59 AM EDT)
Sensei Biotherapeutics, Inc. Common Stock
SNSENASDAQ • USD
27.56
↗ 0.81 (2.94%)
POST MARKET (AS OF 04:01 PM EDT)
Post Market
AS OF 04:01 PM EDT
27.56
↗ 0.81 (2.94%)
Market: OPEN
Open?$29.11
High?$29.77
Low?$26.38
Prev. Close?$29.11
Volume?26.0K
Avg. Volume?57.3K
VWAP?$27.78
Rel. Volume?0.45x
Bid / Ask
Bid?$23.16 × 100
Ask?$31.67 × 100
Spread?$8.51
Midpoint?$27.42
Valuation & Ratios
Market Cap?39.0M
Shares Out?1.3M
Float?775.9K
Float %?57.9%
P/E Ratio?N/A
P/B Ratio?2.10
EPS?-$15.72
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?5.06Strong
Quick Ratio?5.06Strong
Cash Ratio?2.04Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score100/100
P/E?N/A▾
P/B?2.10CHEAP▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.4CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-113.4%WEAK▾
ROA?-92.1%WEAK▾
Cash Flow & Enterprise
FCF?$-20469000
Enterprise Value?$30.5M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Sensei Biotherapeutics Inc is a clinical-stage biotechnology company engaged in the development of therapies targeting cancer through multi-node inhibition of oncogenic pathways. The company's lead program, PIKTOR, is an investigational oral combination therapy designed to inhibit multiple nodes of the PI3K/AKT/mTOR pathway and is being evaluated for the treatment of endometrial and breast cancers. In addition, the company is advancing other pipeline programs targeting tumor metabolism and signaling pathways.
Employees
29
Market Cap
39.0M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-02-04
Address
1405 RESEARCH BLVD, SUITE 125
ROCKVILLE, MD 20850
Phone: (240) 243-8000
ROCKVILLE, MD 20850
Phone: (240) 243-8000